Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 6/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.42 |
| ▸ | NCOR2 | Q9Y618 | 2/20 | 0.42 |
| ▸ | LPAR1 | Q92633 | 7/20 | 0.40 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.40 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.40 |
| ▸ | LPAR5 | Q9H1C0 | 5/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6554100 | 0.87 | PTGS2 (0.49) | SLC6A9HDAC1HDAC3HDAC2NCOR2 | |
| SCHEMBL6554097 | 0.85 | HDAC1 (0.41) | SLC6A9HDAC1HDAC3HDAC2NCOR2 | |
| SCHEMBL6810353 | 0.83 | HDAC1 (0.46) | HDAC1HDAC3HDAC2NCOR2LPAR1 | |
| SCHEMBL6539902 | 0.82 | HDAC1 (0.49) | HDAC1HDAC3HDAC2NCOR2LPAR1 | |
| SCHEMBL6540809 | 0.82 | CA12 (0.42) | HDAC1HDAC3HDAC2NCOR2LPAR1 | |
| SCHEMBL6541405 | 0.81 | LPAR1 (0.54) | HDAC1HDAC3HDAC2NCOR2LPAR1 | |
| SCHEMBL9823156 | 0.80 | HDAC1 (0.54) | HDAC1HDAC3HDAC2NCOR2LPAR1 | |
| SCHEMBL6540935 | 0.79 | LPAR1 (0.48) | HDAC1HDAC3HDAC2NCOR2LPAR1 | |
| SCHEMBL6802456 | 0.77 | LPAR1 (0.47) | HDAC1HDAC3HDAC2NCOR2LPAR1 | |
| SCHEMBL3695642 | 0.77 | HDAC1 (0.55) | HDAC1HDAC3HDAC2NCOR2LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040138462-A1 | Aminoalcohol derivatives | ASTELLAS PHARMA INC. (JP) | 2004-07-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040138462-A1 | Aminoalcohol derivatives | BPHL, FANCD2, HRH2 | SLC6A9 467/4885HDAC1 1603/4885HDAC3 2501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.